HAVCR2 and COVID-19: For instance, T cells from severe COVID-19 patients show an increased expression of immune-inhibitory molecules, such as programmed cell death protein ligand-1 (PD-L1) and T-cell immunoglobulin and mucin-domain containing-3 (TIM-3).